Destination therapy with ventricular assist devices

Cardiology

Volumn 101, Issue 1-3, 2004, Pages 104-110

  Raman, Jai ^a   Jeevanadam, Valluvan ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Destination therapy; Heart failure; Ventricular assist devices

Indexed keywords

ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLEEDING; DEVICE; EVALUATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; INFECTION; KAPLAN MEIER METHOD; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS FAILURE; RANDOMIZATION; SAFETY; SURVIVAL RATE; THROMBOEMBOLISM;

CARDIOTONIC AGENTS; EQUIPMENT FAILURE ANALYSIS; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 1542614574     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075990     Document Type: Article

References (13)

1. Franco KL: New implantable pulsatile blood pumps; in Franco KL, Verrier ED (eds): Advanced Therapy in Cardiac Surgery, ed 2. London, BC Decker, 2003, pp 537-545.
2. Slater JP, Rose EA, Levin HR, Frazier OH, Roberts JK, Weinberg AD, Oz MC: Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg 1996;62:1321-1328.
3. Branch KR, Dembitsky WP, Peterson KL, Adamson R, Gordon JB, Smith SC Jr, Jaski BE: Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: Implications for chronic support. J Heart Lung Transplant 1994;13:641-651.
4. El-Banaysosy A, Deng M, Loisance DY, Vetter H, Gronda E, Loebe M, Vigano M: The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: A retrospective multi-centre study. Eur J Cardiothorac Surg 1999;15:835-844.
5. Farrar DJ, Buck KE, Coulter JH, Kupa EJ: Portable pneumatic biventricular driver for the Thoratec ventricular assist device. ASAIO J 1997;43:M631-M634.
6. El-Banayosy A, Arusoglu L, Kizner L, Morshuis M, Tenderich G, Pae WE, Korfer R: Preliminary experience with the LionHeart left ventricular assist device in patients with endstage heart failure. Ann Thorac Surg 2003;75:1469-1475.
7. Frazier OH, Dowling RD, Gray LA Jr, Shah NA, Pool TP, Gregoric I: The total artificial heart: Where we stand. Cardiology 2004;101: 117-121.
8. Westaby S: The new rotary blood pumps: An alternative to cardiac transplantation; in Franco KL, Verrier ED (eds): Advanced Therapy in Cardiac Surgery, ed 2. London, BC Decker, 2003, chapter 49, p 504.
9. Frazier OH, Shah NA, Myers TJ, Robertson KD, Gregoric ID, Delgado R: Use of the Flowmaker (Jarvik 2000) left ventricular assist device for destination therapy and bridging to transplantation. Cardiology 2004;101:111-116.
10. Frazier OH, Myers TJ, Gregoric ID, Khan T, Delgado R, Croitoru M, Miller K, Jarvik R, Westaby S: Initial clinical experience with the Jarvik 2000 implantable axial-flow left ventricular assist system. Circulation 2000;105:2855-2860.
11. Westaby S, Banning A, Saito S, Pigott DW, Jin XY, Catarino PA, Robson D, Moorjani N, Kardos A, Poole-Wilson PA, Jarvik R, Frazier OH: Circulatory support for long-term treatment of heart failure: Experience with an intraventricular continuous flow pump. Circulation 2000;105:2588-2591.
12. Maher TR, Butler KC, Poirier VL, Gernes DB: HeartMate left ventricular assist devices: A multigeneration of implanted blood pumps. Artif Organs 2001;25:422-426.
13. Jeevanandam V, Jayakar DV, Anderson A, Martin S, Piccione W Jr, Wynne J, Stephenson LW, Freed PS, Kantrowitz A: Circulatory assistance with a permanent implantable IABP: Initial human experience. Circulation 2002;106 (12 suppl 1):I183-I188.